The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $415.33 million. The enterprise value is $632.87 million.
Market Cap | 415.33M |
Enterprise Value | 632.87M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SKIN has 123.43 million shares outstanding. The number of shares has decreased by -11.33% in one year.
Shares Outstanding | 123.43M |
Shares Change (YoY) | -11.33% |
Shares Change (QoQ) | -3.17% |
Owned by Insiders (%) | 10.03% |
Owned by Institutions (%) | 97.95% |
Float | 70.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 40.82 |
PS Ratio | 1.01 |
Forward PS | 0.99 |
PB Ratio | 6.80 |
P/FCF Ratio | 46.39 |
PEG Ratio | 0.95 |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.59 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 72.74 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 12.67.
Current Ratio | 6.07 |
Quick Ratio | 5.02 |
Debt / Equity | 12.67 |
Debt / EBITDA | n/a |
Debt / FCF | 86.46 |
Interest Coverage | -6.46 |
Financial Efficiency
Return on equity (ROE) is -87.30% and return on invested capital (ROIC) is -16.13%.
Return on Equity (ROE) | -87.30% |
Return on Assets (ROA) | -10.30% |
Return on Capital (ROIC) | -16.13% |
Revenue Per Employee | $451,749 |
Profits Per Employee | -$113,639 |
Employee Count | 881 |
Asset Turnover | 0.41 |
Inventory Turnover | 2.42 |
Taxes
Income Tax | -1.77M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.05% in the last 52 weeks. The beta is 1.02, so SKIN's price volatility has been similar to the market average.
Beta (1Y) | 1.02 |
52-Week Price Change | -74.05% |
50-Day Moving Average | 3.62 |
200-Day Moving Average | 4.56 |
Relative Strength Index (RSI) | 37.70 |
Average Volume (30 Days) | 2,586,750 |
Short Selling Information
The latest short interest is 10.77 million, so 8.73% of the outstanding shares have been sold short.
Short Interest | 10.77M |
Short Previous Month | 12.00M |
Short % of Shares Out | 8.73% |
Short % of Float | 15.32% |
Short Ratio (days to cover) | 2.87 |
Income Statement
In the last 12 months, SKIN had revenue of $397.99 million and -$100.12 million in losses. Loss per share was -$0.76.
Revenue | 397.99M |
Gross Profit | 155.11M |
Operating Income | -130.92M |
Pretax Income | -101.89M |
Net Income | -100.12M |
EBITDA | -53.57M |
EBIT | -88.24M |
Loss Per Share | -$0.76 |
Balance Sheet
The company has $523.03 million in cash and $752.29 million in debt, giving a net cash position of -$229.26 million or -$1.86 per share.
Cash & Cash Equivalents | 523.03M |
Total Debt | 752.29M |
Net Cash | -229.26M |
Net Cash Per Share | -$1.86 |
Equity / Book Value | 59.39M |
Book Value Per Share | 0.48 |
Working Capital | 583.24M |
Cash Flow
In the last 12 months, operating cash flow was $21.75 million and capital expenditures -$13.05 million, giving a free cash flow of $8.70 million.
Operating Cash Flow | 21.75M |
Capital Expenditures | -13.05M |
Free Cash Flow | 8.70M |
FCF Per Share | $0.07 |
Margins
Gross margin is 38.97%, with operating and profit margins of -32.89% and -25.16%.
Gross Margin | 38.97% |
Operating Margin | -32.89% |
Pretax Margin | -25.60% |
Profit Margin | -25.16% |
EBITDA Margin | -13.46% |
EBIT Margin | -22.17% |
FCF Margin | 2.19% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 11.33% |
Shareholder Yield | 11.33% |
Earnings Yield | -24.81% |
FCF Yield | 2.16% |
Analyst Forecast
The average price target for SKIN is $4.50, which is 33.53% higher than the current price. The consensus rating is "Hold".
Price Target | $4.50 |
Price Target Difference | 33.53% |
Analyst Consensus | Hold |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 7.46% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.43 |
Piotroski F-Score | 4 |